Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. TSLA
9. BRZE
10. GOOGL

Go back to Pharmacyclics, Inc. (PCYC) Posts Q2 Loss of 26c/Share

Big Beat for Pharmacyclics' (PCYC) Imbruvica - Baird

August 1, 2014 7:18 AM EDT

Baird analyst Brian Skorney reiterated an Outperform rating and $173 price target on Pharmacyclics (NASDAQ: PCYC) following Q2 results with Imbruvica putting up a big beat.

"We believe the substantial top-line beat will result in broad increases in consensus estimates as well as a... More

WallachBeth Capital Upgrades Pharmacyclics (PCYC) to Buy

August 1, 2014 6:52 AM EDT

WallachBeth Capital upgraded Pharmacyclics (NASDAQ: PCYC) from Hold to Buy.

For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.

Shares of Pharmacyclics closed at $120.44 yesterday.

... More